Sex-specific environmental influences on the development of autoimmune diseases

Clinical Immunology

Volumn 149, Issue 2, 2013, Pages 182-191

  Tiniakou, Eleni ^a   Costenbader, Karen H ^b   Kriegel, Martin A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmunity; Chemicals; Commensal bacteria; Infectious agents; Microbiota; Smoking

Indexed keywords

ALPHA INTERFERON; ASBESTOS; COSMETIC; ESTROGEN; GAMMA INTERFERON; HAIR DYE; INTERLEUKIN 17; NAIL POLISH; PRISTANE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADDISON DISEASE; ALVEOLAR BONE LOSS; ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CELIAC DISEASE; CHRONIC INFLAMMATION; COMMENSAL; CYTOKINE PRODUCTION; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECTOPIC TISSUE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENERAL DEVICE; GIANT CELL ARTERITIS; GOODPASTURE SYNDROME; GRAVES DISEASE; HIGH RISK POPULATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; INCIDENCE; INNATE IMMUNITY; INTESTINE FLORA; LIPSTICK; LYMPHATIC SYSTEM DISEASE; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PERNICIOUS ANEMIA; PLEIOTROPY; PORPHYROMONAS GINGIVALIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; SOCIAL BEHAVIOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TH2 CELL; ULTRAVIOLET RADIATION; VITILIGO;

AUTOIMMUNITY; CHEMICALS; COMMENSAL BACTERIA; INFECTIOUS AGENTS; MICROBIOTA; SMOKING;

AUTOIMMUNE DISEASES; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 84886089309     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.02.011     Document Type: Review

References (91)

1. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 2007, 28:1-6.
2. Amur S., Parekh A., Mummaneni P. Sex differences and genomics in autoimmune diseases. J. Autoimmun. 2012, 38:J254-J265.
3. Pollard K.M. Gender differences in autoimmunity associated with exposure to environmental factors. J. Autoimmun. 2012, 38:J177-J186.
4. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
5. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nature reviews. Immunology 2010, 10:594-604.
6. Lockshin M.D. Invited review: sex ratio and rheumatic disease. J. Appl. Physiol. 2001, 91:2366-2373.
7. Smith-Bouvier D.L., Divekar A.A., Sasidhar M., Du S., Tiwari-Woodruff S.K., King J.K., Arnold A.P., Singh R.R., Voskuhl R.R. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 2008, 205:1099-1108.
8. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. J. Autoimmun. 2012, 38:J282-J291.
9. Jacob C.O., Zhu J., Armstrong D.L., Yan M., Han J., Zhou X.J., Thomas J.A., Reiff A., Myones B.L., Ojwang J.O., Kaufman K.M., Klein-Gitelman M., McCurdy D., Wagner-Weiner L., Silverman E., Ziegler J., Kelly J.A., Merrill J.T., Harley J.B., Ramsey-Goldman R., Vila L.M., Bae S.C., Vyse T.J., Gilkeson G.S., Gaffney P.M., Moser K.L., Langefeld C.D., Zidovetzki R., Mohan C. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6256-6261.
10. Crotty S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29:621-663.
11. Lichtman E.I., Helfgott S.M., Kriegel M.A. Emerging therapies for systemic lupus erythematosus-focus on targeting interferon-alpha. Clin. Immunol. 2012, 143:210-221.
12. Pauklin S., Sernandez I.V., Bachmann G., Ramiro A.R., Petersen-Mahrt S.K. Estrogen directly activates AID transcription and function. J. Exp. Med. 2009, 206:99-111.
13. Gender Differences in Susceptibility to Environmental Factors: a Priority Assessment: Workshop Report 1998, National Academies Press (US), Washington (DC). V.P. Setlow, C.E. Lawson, N.F. Woods (Eds.).
14. Cooper G.S., Gilbert K.M., Greidinger E.L., James J.A., Pfau J.C., Reinlib L., Richardson B.C., Rose N.R. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ. Heal. Perspect. 2008, 116:695-702.
15. Gabory A., Attig L., Junien C. Sexual dimorphism in environmental epigenetic programming. Mol. Cell. Endocrinol. 2009, 304:8-18.
16. Khuder S.A., Peshimam A.Z., Agraharam S. Environmental risk factors for rheumatoid arthritis. Rev. Environ. Heal. 2002, 17:307-315.
17. McCormic Z.D., Khuder S.S., Aryal B.K., Ames A.L., Khuder S.A. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int. Arch. Occup. Environ. Heal. 2010, 83:763-769.
18. Makol A., Reilly M.J., Rosenman K.D. Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am. J. Ind. Med. 2011, 54:255-262.
19. Stolt P., Kallberg H., Lundberg I., Sjogren B., Klareskog L., Alfredsson L. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann. Rheum. Dis. 2005, 64:582-586.
20. Stolt P., Yahya A., Bengtsson C., Kallberg H., Ronnelid J., Lundberg I., Klareskog L., Alfredsson L. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:1072-1076.
21. Barnes J., Mayes M.D. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr. Opin. Rheumatol. 2012, 24:165-170.
22. Burns C.J., Laing T.J., Gillespie B.W., Heeringa S.G., Alcser K.H., Mayes M.D., Wasko M.C., Cooper B.C., Garabrant D.H., Schottenfeld D. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J. Rheumatol. 1996, 23:1904-1911.
23. Cooper G., Gilbert K., Greidinger E., James J., Pfau J., Reinlib L., Richardson B., Rose N. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Cienc. Saude Colet. 2009, 14:1865-1876.
24. Cooper G.S., Wither J., Bernatsky S., Claudio J.O., Clarke A., Rioux J.D., Fortin P.R. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford) 2010, 49:2172-2180.
25. Tervaert J.W., Stegeman C.A., Kallenberg C.G. Silicon exposure and vasculitis. Curr. Opin. Rheumatol. 1998, 10:12-17.
26. Parks C.G., Walitt B.T., Pettinger M., Chen J.C., de Roos A.J., Hunt J., Sarto G., Howard B.V. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res. 2011, 63:184-194.
27. Finckh A., Cooper G.S., Chibnik L.B., Costenbader K.H., Watts J., Pankey H., Fraser P.A., Karlson E.W. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum. 2006, 54:3648-3654.
28. Hoovestol R.A., Mikuls T.R. Environmental exposures and rheumatoid arthritis risk. Curr. Rheumatol. Rep. 2011, 13:431-439.
29. Sugiyama D., Nishimura K., Tamaki K., Tsuji G., Nakazawa T., Morinobu A., Kumagai S. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann. Rheum. Dis. 2010, 69:70-81.
30. Uhlig T., Hagen K.B., Kvien T.K. Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J. Rheumatol. 1999, 26:47-54.
31. Stolt P., Bengtsson C., Nordmark B., Lindblad S., Lundberg I., Klareskog L., Alfredsson L. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann. Rheum. Dis. 2003, 62:835-841.
32. Padyukov L., Silva C., Stolt P., Alfredsson L., Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004, 50:3085-3092.
33. Heliovaara M., Aho K., Aromaa A., Knekt P., Reunanen A. Smoking and risk of rheumatoid arthritis. J. Rheumatol. 1993, 20:1830-1835.
34. Krishnan E., Sokka T., Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:R158-R162.
35. Reckner Olsson A., Skogh T., Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann. Rheum. Dis. 2001, 60:934-939.
36. Vessey M.P., Villard-Mackintosh L., Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 1987, 35:457-464.
37. Voigt L.F., Koepsell T.D., Nelson J.L., Dugowson C.E., Daling J.R. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994, 5:525-532.
38. Symmons D.P., Bankhead C.R., Harrison B.J., Brennan P., Barrett E.M., Scott D.G., Silman A.J. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum. 1997, 40:1955-1961.
39. Hernandez Avila M., Liang M.H., Willett W.C., Stampfer M.J., Colditz G.A., Rosner B., Roberts W.N., Hennekens C.H., Speizer F.E. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990, 1:285-291.
40. Hazes J.M., Dijkmans B.A., Vandenbroucke J.P., de Vries R.R., Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann. Rheum. Dis. 1990, 49:980-982.
41. Karlson E.W., Lee I.M., Cook N.R., Manson J.E., Buring J.E., Hennekens C.H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 1999, 42:910-917.
42. Criswell L.A., Merlino L.A., Cerhan J.R., Mikuls T.R., Mudano A.S., Burma M., Folsom A.R., Saag K.G. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am. J. Med. 2002, 112:465-471.
43. Costenbader K.H., Feskanich D., Mandl L.A., Karlson E.W. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am. J. Med. 2006, 119:503. (e501-509).
44. Costenbader K.H., Karlson E.W. Cigarette smoking and autoimmune disease: what can we learn from epidemiology?. Lupus 2006, 15:737-745.
45. Lahiri M., Morgan C., Symmons D.P., Bruce I.N. Modifiable risk factors for RA: prevention, better than cure?. Rheumatology (Oxford) 2012, 51:499-512.
46. Bergstrom U., Jacobsson L.T., Nilsson J.A., Berglund G., Turesson C. Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 2011, 50:2005-2013.
47. Costenbader K.H., Karlson E.W. Cigarette smoking and systemic lupus erythematosus: a smoking gun?. Autoimmunity 2005, 38:541-547.
48. Costenbader K.H., Kim D.J., Peerzada J., Lockman S., Nobles-Knight D., Petri M., Karlson E.W. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004, 50:849-857.
49. Freni-Titulaer L.W., Kelley D.B., Grow A.G., McKinley T.W., Arnett F.C., Hochberg M.C. Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am. J. Epidemiol. 1989, 130:404-409.
50. Petri M., Allbritton J. Hair product use in systemic lupus erythematosus. A case-control study. Arthritis Rheum. 1992, 35:625-629.
51. Reidenberg M.M., Drayer D.E., Lorenzo B., Strom B.L., West S.L., Snyder E.S., Freundlich B., Stolley P.D. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum. 1993, 36:971-973.
52. Sanchez-Guerrero J., Karlson E.W., Colditz G.A., Hunter D.J., Speizer F.E., Liang M.H. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1996, 39:657-662.
53. Hardy C.J., Palmer B.P., Muir K.R., Powell R.J. Systemic lupus erythematosus (SLE) and hair treatment: a large community based case-control study. Lupus 1999, 8:541-544.
54. Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., Gilkeson G.S. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J. Rheumatol. 2001, 28:2653-2656.
55. Wang J., Kay A.B., Fletcher J., Formica M.K., McAlindon T.E. Is lipstick associated with the development of systemic lupus erythematosus (SLE)?. Clin. Rheumatol. 2008, 27:1183-1187.
56. Olsson A.R., Skogh T., Wingren G. Occupational determinants for rheumatoid arthritis. Scand. J. Work. Environ. Heal. 2000, 26:243-249.
57. Olsson A.R., Skogh T., Axelson O., Wingren G. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup. Environ. Med. 2004, 61:233-238.
58. Smith D.L., Dong X., Du S., Oh M., Singh R.R., Voskuhl R.R. A female preponderance for chemically induced lupus in SJL/J mice. Clin. Immunol. 2007, 122:101-107.
59. Reeves W.H., Lee P.Y., Weinstein J.S., Satoh M., Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009, 30:455-464.
60. Summers S.A., Hoi A., Steinmetz O.M., O'Sullivan K.M., Ooi J.D., Odobasic D., Akira S., Kitching A.R., Holdsworth S.R. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J. Autoimmun. 2010, 35:291-298.
61. Herman S., Kny A., Schorn C., Pfatschbacher J., Niederreiter B., Herrmann M., Holmdahl R., Steiner G., Hoffmann M.H. Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils. Autoimmunity 2012, 45:602-611.
62. Minhas U., Das P., Bhatnagar A. Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus. Lupus 2011, 20:1421-1425.
63. Dahlgren J., Takhar H., Anderson-Mahoney P., Kotlerman J., Tarr J., Warshaw R. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. Environ. Health 2007, 6:8.
64. Love L.A., Weinberg C.R., McConnaughey D.R., Oddis C.V., Medsger T.A., Reveille J.D., Arnett F.C., Targoff I.N., Miller F.W. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009, 60:2499-2504.
65. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol. 2001, 1:983-993.
66. Panchanathan R., Choubey D. Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity. Mol. Immunol. 2013, 53:15-23.
67. Hughes G.C. Progesterone and autoimmune disease. Autoimmun. Rev. 2012, 11:A502-A514.
68. Gourdy P., Araujo L.M., Zhu R., Garmy-Susini B., Diem S., Laurell H., Leite-de-Moraes M., Dy M., Arnal J.F., Bayard F., Herbelin A. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood 2005, 105:2415-2420.
69. Costenbader K.H., Feskanich D., Stampfer M.J., Karlson E.W. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007, 56:1251-1262.
70. Chighizola C., Meroni P.L. The role of environmental estrogens and autoimmunity. Autoimmun. Rev. 2012, 11:A493-A501.
71. Ehlers S., Kaufmann S.H. Infection, inflammation, and chronic diseases: consequences of a modern lifestyle. Trends Immunol. 2010, 31:184-190.
72. Klein S.L. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol. 2004, 26:247-264.
73. Cook I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26:3551-3555.
74. Frisancho-Kiss S., Davis S.E., Nyland J.F., Frisancho J.A., Cihakova D., Barrett M.A., Rose N.R., Fairweather D. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J. Immunol. 2007, 178:6710-6714.
75. James J.A., Harley J.B., Scofield R.H. Epstein-Barr virus and systemic lupus erythematosus. Curr. Opin. Rheumatol. 2006, 18:462-467.
76. Rose N.R. Infection, mimics, and autoimmune disease. J. Clin. Investig. 2001, 107:943-944.
77. Blank M., Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin. Immunol. 2004, 112:190-199.
78. Ahmed S.A., Hissong B.D., Verthelyi D., Donner K., Becker K., Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Heal. Perspect. 1999, 107(Suppl. 5):681-686.
79. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
80. A framework for human microbiome research. Nature 2012, 486:215-221.
81. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
82. Yu J.J., Ruddy M.J., Conti H.R., Boonanantanasarn K., Gaffen S.L. The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect. Immun. 2008, 76:4206-4213.
83. Scher J.U., Abramson S.B. The microbiome and rheumatoid arthritis. Nature reviews. Rheumatology 2011, 7:569-578.
84. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., Littman D.R., Benoist C., Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
85. Gomez A., Luckey D., Yeoman C.J., Marietta E.V., Berg Miller M.E., Murray J.A., White B.A., Taneja V. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 2012, 7:e36095.
86. Kriegel M.A., Sefik E., Hill J.A., Wu H.J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11548-11553.
87. Markle J.G., Frank D.N., Mortin-Toth S., Robertson C.E., Feazel L.M., Rolle-Kampczyk U., von Bergen M., McCoy K.D., Macpherson A.J., Danska J.S. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013, 339(6123):1084-1088.
88. Miller F.W., Alfredsson L., Costenbader K.H., Kamen D.L., Nelson L.M., Norris J.M., De Roos A.J. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J. Autoimmun. 2012, 39(4):259-271.
89. Willinger T., Rongvaux A., Strowig T., Manz M.G., Flavell R.A. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 2011, 32:321-327.
90. Zhang M.A., Rego D., Moshkova M., Kebir H., Chruscinski A., Nguyen H., Akkermann R., Stanczyk F.Z., Prat A., Steinman L., Dunn S.E. Peroxisome proliferator-activated receptor (PPAR)alpha and -gamma regulate IFNgamma and IL-17A production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9505-9510.
91. Selmi C., Leung P.S., Sherr D.H., Diaz M., Nyland J.F., Monestier M., Rose N.R., Gershwin M.E. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J. Autoimmun. 2012, 39:272-284.